brain stimulant-Sohag University-stuttering

The term **brain stimulant-Sohag University-stuttering** refers to a pharmacological intervention used in a clinical trial (NCT03101306) conducted by Sohag University to treat stuttering in children. In the context of this study, the drug is categorized as a 'medical treatment' or 'brain stimulant' and is compared against speech therapy alone and hyperbaric oxygen therapy. While the specific chemical entity is not explicitly named in the primary trial registration, the term 'brain stimulant' in this clinical and geographic context often refers to nootropic agents or CNS stimulants intended to enhance neuroplasticity or neuromodulation in speech centers. The trial aims to evaluate whether the addition of such a pharmacological agent to standard fluency-shaping speech therapy improves outcomes for pediatric patients with stuttering.

Other names

medical treatment (brain stimulant)